For the past 18 years, leading drug and medical device lawyers have gathered in New York to network with their peers, and craft strategies to surmount new litigation challenges. Now in its 19th year, ACI’S DRUG AND MEDICAL DEVICE LITIGATION is widely regarded as the year’s premier products liability forum.

Network with the “who’s who” of the products liability space

This year’s speaking faculty is comprised of more than 20 in-house counsel, leading products liability litigators for the top law firms, prominent government enforcers, and renowned members of the state and federal bench, providing advice for defeating claims and litigating more efficiently. We are pleased to announce that Kelsey A. Schaefer, Associate Chief Counsel for Enforcement in the Office of General Counsel at the FDA will be offering keynote remarks.

Hear how your industry peers are responding to Crises caused by adverse events and government investigations

A crisis management plan is becoming increasingly important to drug and device manufacturers. When faced with a product recall, government investigation, or respected journal that negatively discusses one of your products, your company needs a proactive media relations strategy. In-house counsel must coordinate crisis efforts between the legal and business side of the business and know when to bring in the expertise of outside counsel or a PR firm. Expert speakers will help you to develop a crisis checklist to use before, during and after the manufacturer’s response.

Highly tailored track sessions enable attendees to focus on core areas of interest

In response to industry feedback, this year’s conference will feature two distinct tracks – one aimed at honing your trial strategies, and the other aimed at the biggest challenges faced by in-house drug and device attorneys. Over the course of an afternoon, attendees will learn the latest trial tactics, from Voir Dire to Daubert, with commentary by The Honorable John Tunheim. For attendees of the in-house track, challenges such as Case Management, Duty to Train, and Government Investigations will be addressed.

Recurring highlights of this annual program include:

  • Multiple networking opportunities including lunches, breaks and cocktail receptions
  • Complimentary participation in the Pre-conference Speed Networking facilitated by in-house counsel
  • The Judicial Panel featuring 7 renowned state and federal jurists, each with distinguished records of industry mass torts oversight
  • Post-Conference Business Development Master Class on Selecting and Evaluating Outside Counsel

Since its inception, New York City has been the backdrop for Drug and Medical Device Litigation, providing many excellent networking opportunities for the 400+ drug and medical device industry professionals attending the conference.

Register early to ensure best pricing. Group discounts are available. Call 1-888-224-2480, fax your registration to 1-877-927-1563, or online.

Join the ACI: Drug and Medical Device Litigation group on LinkedIn to ‘meet’ your peers prior to the start of the conference; and follow us on Twitter @DrugandMed for industry news and exclusive discounts.
I look forward to seeing you in December!

Kind Regards,

Stephanie Butler
Division Manager